TNFSF10 and hepatocellular carcinoma: The TRAIL mutant with residues 132–135 deletion showed a profound decrease in the binding affinity for sDR5 and cytotoxic activity in vitro using human hepatoma cells, suggesting those residues bear direct correlation with the activity of TRAIL [19].